HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vickie Y Jo Selected Research

hypoiodous acid (HOI)

1/2018Surgical Management of Primary Retroperitoneal Sarcomas: Rationale for Selective Organ Resection.
5/2017Incidence and Adverse Prognostic Implications of Histopathologic Organ Invasion in Primary Retroperitoneal Sarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vickie Y Jo Research Topics

Disease

34Neoplasms (Cancer)
03/2022 - 03/2010
7Squamous Cell Carcinoma of Head and Neck
01/2022 - 06/2012
4Carcinoma (Carcinomatosis)
01/2022 - 03/2010
3Sarcoma (Soft Tissue Sarcoma)
10/2020 - 05/2017
3Leiomyosarcoma
01/2018 - 08/2015
3Adenocarcinoma
01/2016 - 04/2014
2Adenoid Cystic Carcinoma (Cylindroma)
01/2022 - 10/2019
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2021 - 10/2020
2Papillary Thyroid Cancer
03/2018 - 10/2016
2Liposarcoma
01/2018 - 05/2017
2Neurofibrosarcoma (MPNST)
08/2017 - 05/2015
1Rhabdomyoma
12/2022
1Plasma Cell Granuloma
03/2022
1Squamous Cell Neoplasms (Squamous Cell Cancer)
03/2022
1Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma)
01/2022
1Acinar Cell Carcinoma
06/2021
1Extranodal Extension
10/2020
1Hemangiosarcoma (Angiosarcoma)
10/2020
1Pathologic Complete Response
10/2020
1Foreign Bodies (Foreign Body)
03/2020
1Wounds and Injuries (Trauma)
03/2020
1Tracheobronchomalacia
03/2020
1Salivary Gland Neoplasms (Salivary Gland Cancer)
01/2020
1Myoepithelioma
10/2019
1Soft Tissue Neoplasms
09/2018
1Synovial Sarcoma (Synovioma)
06/2017
1Myopericytoma
06/2017
1Hemangiopericytoma
06/2017
1Tongue Neoplasms (Tongue Neoplasm)
01/2017
1Multiple Hamartoma Syndrome (Cowden's Disease)
04/2016
1Adenoma (Adenomas)
01/2016
1Neurilemmoma (Schwannoma)
05/2015
1Renal Cell Carcinoma (Grawitz Tumor)
05/2015
1renal Oncocytoma
05/2015
1Interdigitating Dendritic Cell Sarcoma
10/2014
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
08/2014
1Chordoma
08/2014
1Chondrosarcoma
08/2014
1Mesothelioma
04/2014
1Malignant Mesothelioma
04/2014

Drug/Important Bio-Agent (IBA)

8Biomarkers (Surrogate Marker)IBA
03/2022 - 06/2012
6Keratins (Keratin)IBA
01/2022 - 05/2013
5S100 Proteins (S 100 Protein)IBA
10/2019 - 05/2013
5Proteins (Proteins, Gene)FDA Link
09/2018 - 03/2010
4RNA (Ribonucleic Acid)IBA
12/2022 - 08/2015
4DNA (Deoxyribonucleic Acid)IBA
12/2022 - 01/2016
3DesminIBA
01/2021 - 10/2011
3ParaffinIBA
01/2016 - 04/2014
2NivolumabIBA
01/2022 - 10/2020
2pembrolizumabIBA
01/2021 - 10/2020
2Mutant Proteins (Protein, Mutant)IBA
01/2018 - 01/2017
2hypoiodous acid (HOI)IBA
01/2018 - 05/2017
2CateninsIBA
06/2017 - 01/2016
2Formaldehyde (Formol)FDA Link
01/2016 - 08/2015
1Glucose (Dextrose)FDA LinkGeneric
03/2022
1lirilumabIBA
01/2022
1VimentinIBA
01/2022
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2021
1Member 3 Group A Nuclear Receptor Subfamily 4IBA
06/2021
1IpilimumabIBA
10/2020
1nitinolIBA
03/2020
1titanium nickelide (Ni-Ti)IBA
03/2020
1Eosine Yellowish-(YS) (Eosin)IBA
03/2020
1Hematoxylin (Haematoxylon)IBA
03/2020
1ChromatinIBA
01/2020
1Trastuzumab (Herceptin)FDA Link
01/2020
1AndrogensIBA
01/2020
1Androgen Receptors (Androgen Receptor)IBA
01/2020
1SynaptophysinIBA
01/2019
1Indicators and Reagents (Reagents)IBA
06/2018
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2018
1Mucin-1 (CA 15-3 Antigen)IBA
08/2017
1Capsules (Microcapsules)IBA
08/2017
1Histones (Histone)IBA
08/2017
1MicroRNAs (MicroRNA)IBA
01/2017
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
04/2016
1TensinsIBA
04/2016
1AntigensIBA
03/2015
1Brachyury protein (Brachyury)IBA
08/2014
1Claudin-4IBA
04/2014
1Myosins (Myosin)IBA
11/2013
1Cyclin D1IBA
06/2012
1CalreticulinIBA
03/2010
1Histocompatibility Antigens Class IIBA
03/2010

Therapy/Procedure

6Therapeutics
03/2022 - 08/2015
2Conservative Treatment
03/2018 - 10/2016
2Drug Therapy (Chemotherapy)
05/2015 - 10/2014
1Immunotherapy
03/2022
1Time-to-Treatment
01/2022
1Stents
03/2020
1Radiotherapy
10/2014